Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
03
2021
accepted:
26
04
2021
entrez:
7
5
2021
pubmed:
8
5
2021
medline:
25
2
2023
Statut:
epublish
Résumé
Oral contraceptive pills (OCPs) are considered one of the most important birth control methods globally. However, these pills were designed for female administration rather than males. This study was designed to investigate patterns of OCPs use and abuse among Jordanian males, according to the community pharmacists' observations. A mixed-method explanatory sequential study was conducted using an online self-administered survey, followed by semi-structured in-depth interviews for registered pharmacists, assistant pharmacists and pharmacy interns. The interviews were utilized using a conceptual framework. Inductive thematic analysis and descriptive/regression analyses were completed using Nvivo and SPSS, respectively. A total of 158 questionnaire responses and 22 interviews were included in our analysis. Around half (48.4%) of the questionnaire responses confirmed that males could use OCPs for hair growth enhancement, muscle gain and acne treatment 12.7%, 31.7% and 4.4%, respectively. Through the interviews, the participating pharmacists highlighted that males use OCPs mostly for bodybuilding purposes, according to recommendations by their coaches at the gym. The most abused OCPs containing estrogen (Ethinyl estradiol) and progestins (Drospirenone or Levonorgestrel). This study provided insight into unexpected uses of OCPs by males in Jordan. Community pharmacists have a crucial role in the management of OCPs use and abuse. However, restricted regulations and monitoring must be released and implemented on the community to limit such practices.
Sections du résumé
BACKGROUND
Oral contraceptive pills (OCPs) are considered one of the most important birth control methods globally. However, these pills were designed for female administration rather than males. This study was designed to investigate patterns of OCPs use and abuse among Jordanian males, according to the community pharmacists' observations.
METHOD
A mixed-method explanatory sequential study was conducted using an online self-administered survey, followed by semi-structured in-depth interviews for registered pharmacists, assistant pharmacists and pharmacy interns. The interviews were utilized using a conceptual framework. Inductive thematic analysis and descriptive/regression analyses were completed using Nvivo and SPSS, respectively.
RESULTS
A total of 158 questionnaire responses and 22 interviews were included in our analysis. Around half (48.4%) of the questionnaire responses confirmed that males could use OCPs for hair growth enhancement, muscle gain and acne treatment 12.7%, 31.7% and 4.4%, respectively. Through the interviews, the participating pharmacists highlighted that males use OCPs mostly for bodybuilding purposes, according to recommendations by their coaches at the gym. The most abused OCPs containing estrogen (Ethinyl estradiol) and progestins (Drospirenone or Levonorgestrel).
CONCLUSION
This study provided insight into unexpected uses of OCPs by males in Jordan. Community pharmacists have a crucial role in the management of OCPs use and abuse. However, restricted regulations and monitoring must be released and implemented on the community to limit such practices.
Identifiants
pubmed: 33961665
doi: 10.1371/journal.pone.0251302
pii: PONE-D-21-07823
pmc: PMC8104375
doi:
Substances chimiques
Contraceptives, Oral, Combined
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0251302Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Int Nurs Rev. 2005 Jun;52(2):109-14
pubmed: 15842323
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Mater Sociomed. 2018 Mar;30(1):49-52
pubmed: 29670477
Medicine (Baltimore). 2019 Aug;98(33):e16440
pubmed: 31415348
Int J Endocrinol Metab. 2013 Winter;11(1):41-7
pubmed: 23853619
J Clin Endocrinol Metab. 2019 Feb 1;104(2):423-432
pubmed: 30252061
Curr Opin Endocrinol Diabetes Obes. 2012 Jun;19(3):211-9
pubmed: 22450858
Adv Clin Chem. 2016;76:123-63
pubmed: 27645818
Drugs. 2010 Aug 20;70(12):1487-503
pubmed: 20687617
Prim Care. 2011 Mar;38(1):41-58
pubmed: 21356420
BMJ Glob Health. 2019 Jun 25;4(3):e001402
pubmed: 31321085
N Engl J Med. 2013 Sep 12;369(11):1011-22
pubmed: 24024838
BMJ. 2004 May 29;328(7451):1312-5
pubmed: 15166072
Res Social Adm Pharm. 2019 Jun;15(6):650-655
pubmed: 30143467
Fertil Steril. 2003 Jan;79(1):203-5
pubmed: 12524089
Am J Addict. 2011 Jan-Feb;20(1):9-13
pubmed: 21175915
Front Physiol. 2019 Jul 02;10:824
pubmed: 31312144
BMC Womens Health. 2015 Dec 14;15:117
pubmed: 26654875
Medsurg Nurs. 2016 Nov;25(6):435-6
pubmed: 30304614
Subst Use Misuse. 2010 Jul;45(9):1319-29
pubmed: 20509736
J Gerontol A Biol Sci Med Sci. 2012 Oct;67(10):1005-13
pubmed: 22389460
PLoS One. 2020 Dec 21;15(12):e0244373
pubmed: 33347511
Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):185-194
pubmed: 29369917
Pharmacy (Basel). 2019 Jul 18;7(3):
pubmed: 31323818
Int J Environ Res Public Health. 2020 Jan 15;17(2):
pubmed: 31952127
BMC Womens Health. 2019 Jun 3;19(1):72
pubmed: 31159800
Int J Obes (Lond). 2018 Jun;42(5):953-963
pubmed: 29777228
Eur J Public Health. 2008 Dec;18(6):661-5
pubmed: 18603598
Pharmacotherapy. 2011 Apr;31(4):424-37
pubmed: 21449630
Eur J Endocrinol. 2019 Jul;181(1):R23-R43
pubmed: 31096185